share_log

HC Wainwright & Co. Reiterates Buy on Edesa Biotech, Maintains $21 Price Target

Moomoo 24/7 ·  Feb 14 06:27

HC Wainwright & Co. analyst Vernon Bernardino reiterates Edesa Biotech (NASDAQ:EDSA) with a Buy and maintains $21 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment